Search (News)

Oncoinvent Announces Publication Of Normal Tissue Dosimetry Results In Journal Of Nuclear Medicine

english top health

(MENAFN - PR Newswire) Clinical dosimetry results from Phase 1 studies of Radspherin – in ovarian and colorectal cancer demonstrate absorbed doses to normal organs well below values associated ...
2026-08-11 01:31:24